| Literature DB >> 27375850 |
Mikias Negash1, Aster Tsegaye1, Amha G/Medhin2.
Abstract
BACKGROUND: Bone marrow examination may be required to discriminate causes of thrombocytopenia as hypoproductive or hyperdestructive. However, this procedure is invasive and time consuming. This study assessed the diagnostic value of Mean Platelet Volume (MPV), Platelet Distribution Width (PDW) and Platelet Large Cell-Ratio (P-LCR) in discriminating causes of thrombocytopenia as hypoproductive or hyperdestructive (Immune thrombocytopenia purpura).Entities:
Keywords: Bone marrow; Hypoproductive thrombocytopenia; Immune thrombocytopenia purpura (hyperdestructive thrombocytopenia); Platelet indices
Year: 2016 PMID: 27375850 PMCID: PMC4930598 DOI: 10.1186/s12878-016-0057-5
Source DB: PubMed Journal: BMC Hematol ISSN: 2052-1839
Socio-demographic characteristics of patients and apparently healthy controls
| Variable | Number | Sex | Age in years Mean (SD) | |
|---|---|---|---|---|
| Male | Female | |||
| Hypoproductive | 50 | 33 | 17 | 41 (17.8) |
| ITP | 33 | 12 | 21 | 27 (16.3) |
| Healthy controls | 42 | 26 | 16 | 25 (6.8) |
| Total | 125 | 71 | 54 | |
Comparison of mean platelet count and mean platelet indices between hypo-productive, ITP patients and healthy controls
MPV mean platelet volume, PDW platelet distribution width, P-LCR platelet larger cell ratio; results are presented as mean, values in bracket are standard deviation; P value was considered significant at level of 0.05
Causes of thrombocytopenia in hypoproductive patients and respective average platelet count and platelet indices
| Diagnosed causes of thrombocytopenia | Number | Pltx109/L | MPV (fl) | PDW (fl) | P-LCR (%) |
|---|---|---|---|---|---|
| BM toxicity secondary to CML chemotherapy | 27 | 72 | 9.5 | 12.3 | 23 |
| ALL on chemotherapy | 5 | 57 | 10 | 13.7 | 27.5 |
| ALL chemotherapy naïve | 2 | 12 | 11 | 13 | 34 |
| Myelodysplastic syndrome | 1 | 88 | 8.8 | 15.3 | 17 |
| AML on chemotherapy | 3 | 77 | 8.5 | 14.4 | 18 |
| Myelofibrosis | 2 | 44.5 | 9.5 | 16.5 | 24 |
| Erythroid hyperplasia | 2 | 77 | 10.4 | 14 | 31 |
| CLL chemotherapy naïve | 4 | 79 | 10.4 | 16.2 | 34 |
| BM toxicity to lymphoma chemotherapy | 4 | 56 | 9.9 | 13 | 25 |
| Total/average | 50 | 70.4 | 9.7 | 13.2 | 25 |
CML chronic myelogenous leukemia, BM bone marrow, ALL acute lymphocytic leukemia, AML Acute myeloid leukemia, CLL chronic lymphocytic leukemia
Fig. 1Correlation between platelet count and MPV, PDW, P-LCR in patients with ITP r = correlation coefficient
Fig. 2ROC curve comparing area covered by MPV, PDW, P-LCR to identify hypoproductive cases among thrombocytopenic patients
Sensitivity and specificity of the platelet indices for diagnosis of hypoproductive thrombocytopenia (bone marrow disease) at different cut off points from ROC curve coordinate
| MPV (fl) | Sensitivity % | Specificity % | P-LCR (%) | Sensitivity % | Specificity % |
| <10.75 | 74 | 70 | <31.4 | 76 | 67 |
| <10.95 | 90 | 67 | <33.15 | 88 | 67 |
| <11.05 | 95 | 67 | <33.7 | 90 | 64 |
| <11.3 | 100 | 61 | <34.3 | 92 | 61 |
| PDW (fl) | |||||
| <15.5 | 76 | 55 | |||
| <15.65 | 80 | 52 | |||
| <15.75 | 82 | 49 | |||
| <15.85 |
Sensitivity and specificity of the platelet indices for diagnosis of ITP at different cut off points from ROC curve coordinates
| MPV (fl) | Sensitivity % | Specificity % | P-LCR (%) | Sensitivity % | Specificity % |
| >11.05 | 67 | 95 | >33.15 | 67 | 88 |
| >10.75 | 70 | 74 | >30.05 | 70 | 70 |
| >10.15 | 85 | 66 | >28 | 82 | 66 |
| >9.95 | 91 | 64 | >26.15 | 88 | 64 |
| PDW (fl) | |||||
| >14.25 | 61 | 62 | |||
| >14.1 | 67 | 40 | |||
| >13.05 | 79 | 50 |
MPV mean platelet volume, PDW platelet distribution width, P-LCR platelet larger cell ratio, ROC receiver operating characteristics curve, ITP immune thrombocytopenia purpura